35
New horizons for animal models in neuroendocrine tumours. Using the zebrafish as model. Jorge Barriuso Marie-Curie Fellow Hurlstone lab University of Manchester

GETNE 2014: New horizons in animal models for ......New horizons for animal models in neuroendocrine tumours. Using the zebrafish as model. Jorge Barriuso Marie-Curie Fellow Hurlstone

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

  • New horizons for animal models in neuroendocrine tumours.

    Using the zebrafish as model.

    Jorge Barriuso Marie-Curie Fellow Hurlstone lab University of Manchester

  • Do  we  need  animal  models?  

    Oncogenes Tumour suppressor genes

    celullarstroma Immune

    system Vasculature ECM

  • Do  we  need  animal  models?  

  • About  fish  and  men  

    Howe et al 2013 Spitsbergen et al 2012

    •  26000 protein coding genes.

    •  70% of genes have an obvious orthologue.

    •  The fish develops tumours that resemble human ones.

  • pNET  model  

  • Hanahan 1985

  • Cancer   Oncogene   Tumour  suppressor  

    Melanoma   mi#a–BRAFV600E  mi#a:EGFP:NRASQ61K  

    kita–Gal4  ×  uas-‐HRAS  

    tp53−/−  

    PDAC   p#1a–KRASG12V–GFP  p#1a:Gal4–VP16  ×  uas–KRASG12V–GFP  

    T  cell  lymph/leuk   rag2–myc  rag2–lox–dsRED2–lox–EGFP–mMyc  ×  hsp70–cre  rag2–NOTCH1  rag2–myc  ×  rag2–bcl2  

    B  cell  leuk   B  acQn–TEL–AML1  (ETV6–RUNX1)  

    Rhabdomyosarcoma   rag2–KRASG12D  

    Neuroblastoma   dβh:EGFP–MYCN  dβh:EGFP  and  dβh:ALKF1174L  

    AML   pu1–MYST3/NCOA2–EGFP  

    MPNST   tp53−/−  

    Ewing’s   hsp70  or  β-‐acQn–EWSR1–FLI1   tp53−/−  

    Liver   fabp10:LexPR;  LexA:EGFP  ×  cryB:mCherry;  LexA:EGFP–krasG12V  

    fabp10:TA;  TRE:xmrk;  krt4:GFP  

    PNET   zmyod–MYCN  

    CorQcotroph  adenoma   POMC–PTTG  

    TesQcular  germ    cell  t.   fugu  flck–SV40  large  T  

    Adapted from White et al 2013

  • pNET  and  zebrafish  

    •  Serendipity

    •  Z-myod: NMYC

    •  Low penetrance

    •  Strain not stable

    Yang et al 2013

  • Transgenesis  in  zebrafish  

    Prom.   oncogene  

    linker  

    reporter  

    Conditional expression model +

    reporter

    Ins.  prom   STOP   STOP  reporter1   oncogene  

    linker  

    reporter2  

    Conditional expression model + reporter + inducible

    Prom.   oncogene   Conditional expression model

  • pNET  model  design  

    Ins.  prom   STOP   STOP  eBFP2   NMYC  

    P2A   mCherry  

    Crys.  pro   eCFP  

    Ins.  prom   NMYC  

    P2A   mCherry  

    Crys.  pro   eCFP  

  • Casper. Ubi:CreERT

    + TAM

    pNET  model  (“Riddicks”)  

    X 20

  • Targets  of  interest  for  KO    

  • Genome-‐ediBng  strategies  

    Adapted from www.addgene.org

    Clustered Regularly Interspaced Short Palindromic Repeats

    Transcription activator-like effector nucleases

  • CRISPR/Cas9  

    Building a positive control...

    Chen et al 2013

  • Genome-‐ediBng  strategies  

    Adapted from www.pnabio.com

  • Images  from  literature  

    Blackburn et al 2014

  • Heterogeneity  with  xenograKs  

    Chapman et al 2014

  • Chapman et al 2014

  • XenograKs  (zf  embryos)  

    Chapman et al 2014.(Hurlstone lab)

    Barriuso (Unpublished data. Hurlstone lab)

    Adapted from Veinotte et al 2014

  • Strategies  

    Nicoli et al 2007

  • Strategies:  new  technique  

    BON cells injected in 2dpf embryo. Imaged at 24 hpi.

    Barriuso (unpublished data)

  • Angiogenesis  assay    

    BON cells injected in 2dpf fli-1:eGFP embryo. Imaged at 24 hpi.

    Barriuso (unpublished data) Nicoli 2007

  • Angiogenesis  assay    

    BON cells injected in 2dpf fli-1:eGFP embryo. Imaged at 24 hpi.

    Two patterns of engraftment

    SIV attraction Cuvier duct disruption

    Barriuso (unpublished data)

  • Angiogenesis  assay    

    BON cells injected in 2dpf fli-1:eGFP embryo. Imaged at 72 hpi.

    Barriuso (unpublished data)

  • Angiogenesis  assay    

    BON cells injected in 2dpf fli-1:eGFP embryo. Imaged at 72 hpi.

    Barriuso (unpublished data)

  • Future:  TumourgraKs  

    PancreaQc  cancer  

    Normal  pancreas  

    2  dpf  embryos  

    Marques et al 2009

  • Hypothesis Co-clinical trials

    +

    Xenografts

    Cell lines Transgenic models

    Tumourgrafts

  • Working  at  a  ZF  facility    

  • Working  at  a  ZF  facility    

    RNA

    DNA

  • Aquarium

  • Conclusions    

    •  The number of transgenic models are increasing. •  The versatility of the fish as model for cancer research makes it adaptable to complex scenarios as intratumoural heterogeneity studies. •  KO models using the latest technologies (CRISPR/cas9) •  Xenograft models. •  The model is valid for well differentiated tumours. • The technologies applied are amenable for high throughput analysis.

    •  Next: tumourgrafts

  • War against cancer

  • Acknowledgements  

    Hurlstone  lab  Adam  Hurlstone  Rags  Nagaraju  Irene  Barrinaga-‐Rementeria  Laura  Fernandez  del  Ama  Anna  Chapman  Chris  Dee  Andy  Badrock  Helen  Young  Hannah  Johnstone  Mai  AbdelaoumuQ  

    Wellbrock  lab  Claudia  Wellbrock  Imanol  Arozarena  

    ChrisQe  NET  team  Juan  Valle  Richard  Hubner  Maréad  McNamara  Angela  Lamarca  Lynn  McCallum  

  • Muchas gracias